Riyadh, Saudi Arabia

Mohamed Boudjelal

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mohamed Boudjelal: An Innovative Force in Cancer Research

Introduction:

In the realm of scientific innovation, Mohamed Boudjelal has made noteworthy contributions, particularly in the field of cancer research. With four patents to his name, Boudjelal has demonstrated his expertise in designing novel compounds and synthetic methodologies. Let's explore his significant patents, research, and professional affiliations.

Background:

Mohamed Boudjelal is a resident of Riyadh, Saudi Arabia and has garnered recognition for his relentless pursuit of groundbreaking discoveries in the medical field. His research focuses mainly on developing new and effective methods of cancer treatment.

Patent 1: Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof.

This patent showcases Boudjelal's expertise in synthesizing novel compounds and outlines a method for cancer treatment using arylidene-1,3-dioxane-4,6-diones. The patented invention delves into a Meldrum's acid-based chemistry and hybrid solid-liquid method, which includes various steps such as component protection, immobilization on a solid phase, introduction of compatible derivatives, among others.

Patent 2: Methods for treating cancer using purine analogs by depleting intracellular ATP.

In this patent, Boudjelal presents an innovative method for treating cancer patients by administering both a purine analog and an agent that depletes intracellular ATP. This groundbreaking approach aims to selectively target cancer cells while preserving healthy cells, potentially enhancing treatment efficacy. Additionally, the patent highlights a method for selecting patients whose cancer cells are susceptible to ATP depletion.

Professional Affiliations:

Throughout his career, Boudjelal has collaborated with renowned healthcare institutions. He served as an integral member of the National Guard Health Affairs and contributed his expertise to the King Saud bin Abdulaziz University for Health Sciences. These affiliations further demonstrate his dedication to advancing cancer research and bringing innovative solutions to patient care.

Colleagues:

Boudjelal's work was not accomplished in isolation, as he collaborated with talented professionals in his research endeavors. Notably, he collaborated with Atef Nehdi and Ahmed Alaskar, whose contributions have undoubtedly complemented his groundbreaking work.

Conclusion:

Mohamed Boudjelal's unwavering dedication to cancer research, evident through his patents and collaborations, highlights his profound contributions to the field of medical science. His inventive approaches and methodologies have the potential to revolutionize cancer treatment, offering hope to patients worldwide. Boudjelal's commitment to innovation and his role in advancing cancer research make him an inspiring figure within the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…